Both FKB prolyl isomerase 1B (FKBP1B) and peroxiredoxin 5 (PRDX5) had higher plasma levels in lung- and colorectal cancer as compared to all the other cancers and were also selected independently by the models for both of these cancer types. This evidence concerns the gene FKBP1B and colorectal cancer.